FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Geritrex Ritussin DM Children & Adults Recall

Ritussin DM Children & Adults, 4 Fl

Geritrex, LLC · Middletown, NY

Risk level
Class II
Reported by FDA
Jul 31, 2019
Recall ID
D-1521-2019
Check your lot numberHow we source this data

Summary

Geritrex recalled Ritussin DM Children & Adults starting May 31, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1521-2019 on Jul 31, 2019. Reason: cGMP Deviations: Products may have microbial contamination. Status: Terminated.

Why it was recalled

cGMP Deviations: Products may have microbial contamination.

Product description

Ritussin DM Children & Adults, 4 Fl. Oz. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-409-04

Lot numbers, UPCs & expiration codes

Lot #: 70602, Exp 6/19

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1521-2019
Classification
Class II
Status
Terminated
Recall initiated
May 31, 2019
FDA report date
Jul 31, 2019
Quantity
5107 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Geritrex, LLC

Original FDA data

Every field from FDA enforcement report D-1521-2019, exactly as published.

Show all FDA fields
City
Middletown
State
NY
Status
Terminated
Country
United States
Event ID
83200
Address
40 Commercial Ave
Code information
Lot #: 70602, Exp 6/19
Postal code
10941-1444
Report date
Jul 31, 2019
Product type
Drugs
Recall number
D-1521-2019
Classification
Class II
Recalling firm
Geritrex, LLC
Product quantity
5107 bottles
Termination date
Feb 2, 2024
Reason for recall
cGMP Deviations: Products may have microbial contamination.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ritussin DM Children & Adults, 4 Fl. Oz. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941, NDC 53807-409-04
Distribution pattern
U.S.A. Nationwide
Recall initiation date
May 31, 2019
Initial firm notification
Letter
Center classification date
Jul 25, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1521-2019, published Jul 31, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls